Glenmark Pharma to study potential Covid-19 drug combination, Health News, ET HealthWorld
[ad_1] BENGALURU: Glenmark Pharmaceuticals Ltd on Tuesday said it would begin a clinical trial in India to test a combination of two antiviral drugs, favipiravir and umifenovir, as a potential COVID-19 treatment. Glenmark has secured Indian regulatory approval for the study, which will aim to enroll 158 inpatients with moderate COVID-19, the company said. Drug …